The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
Open accessAbstract
The ongoing explosion of antibiotic-resistant infections continues to plague global and US health care. Meanwhile, an equally alarming decline has occurred in the research and development of new antibiotics to deal with the threat. In response to this microbial "perfect storm," in 2001, the federal Interagency Task Force on Antimicrobial Resistance released the "Action Plan to Combat Antimicrobial Resistance; Part 1: Domestic" to strengthen the response in the United States. The Infectious Diseases Society of America (IDSA) followed in 2004 with its own report, "Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates, A Public Health Crisis Brews," which proposed incentives to reinvigorate pharmaceutical investment in antibiotic research and development. The IDSA's subsequent lobbying efforts led to the introduction of promising legislation in the 109 th US Congress (January 2005-December 2006). Unfortunately, the legislation was not enacted. During the 110 th Congress, the IDSA has continued to work with congressional leaders on promising legislation to address antibiotic-resistant infection. Nevertheless, despite intensive public relations and lobbying efforts, it remains unclear whether sufficiently robust legislation will be enacted. In the meantime, microbes continue to become more resistant, the antibiotic pipeline continues to diminish, and the majority of the public remains unaware of this critical situation. The result of insufficient federal funding; insufficient surveillance, prevention, and control; insufficient research and development activities; misguided regulation of antibiotics in agriculture and, in particular, for food animals; and insufficient overall coordination of US (and international) efforts could mean a literal return to the preantibiotic era for many types of infections. If we are to address the antimicrobial resistance crisis, a concerted, grassroots effort led by the medical community will be required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Microfossils of the early Archean apex chert: New evidence of the antiquity of life
Schopf, J. W. (1993) · Science · doi:10.1126/science.260.5108.640 · Cited by 1,363
Humans as the World's Greatest Evolutionary Force
Palumbi, S. R. (2001) · Science · doi:10.1126/science.293.5536.1786 · Cited by 1,290
The indigenous gastrointestinal microflora
Berg, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10057-3 · Cited by 1,153
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Self-citationMiller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Self-citationIncreasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Self-citationA Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Early Archean (3.3-Billion to 3.5-Billion-Year-Old) Microfossils from Warrawoona Group, Australia
Schopf, J. W., & Packer, B. M. (1987) · Science · doi:10.1126/science.11539686 · Cited by 655
Microbial Threats to Health: Emergence, Detection, and Response
Smolinski, M. S., Hamburg, M. A., & Lederberg, J. (2003) · Cited by 615
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Global Incidence of Multidrug‐Resistant Tuberculosis
Zignol, M., Hosseini, M. S., Wright, A., Weezenbeek, C. L., Nunn, P., Watt, C. J., Williams, B. G., & Dye, C. (2006) · The Journal of Infectious Diseases · doi:10.1086/505877 · Cited by 524
Lederberg, J. (2000) · Science · doi:10.1126/science.288.5464.287 · Cited by 521
Why is big Pharma getting out of antibacterial drug discovery?
Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503
The antineutrophil cytoplasmic antibody–associated vasculitides
Seo, P., & Stone, J. H. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.030 · Cited by 496
Trends in Infectious Diseases Mortality in the United States
Pinner, R. W. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530270029027 · Cited by 487
Infectious Diseases: Considerations for the 21st Century
Fauci, A. S. (2001) · Clinical Infectious Diseases · doi:10.1086/319235 · Cited by 443
Community-Associated MRSA — Resistance and Virulence Converge
Chambers, H. F. (2005) · New England Journal of Medicine · doi:10.1056/nejme058023 · Cited by 423
Alteration of Oceanic Volcanic Glass: Textural Evidence of Microbial Activity
Fisk, M. R., Giovannoni, S. J., & Thorseth, I. H. (1998) · Science · doi:10.1126/science.281.5379.978 · Cited by 368
Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504476 · Cited by 344
SATTLER, C. A., MASON, E. O., & KAPLAN, S. L. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00005 · Cited by 332
Eady, E. A., & Cove, J. H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200304000-00007 · Cited by 329
Macrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates
Hyde, T. B. (2001) · JAMA · doi:10.1001/jama.286.15.1857 · Cited by 315
Evolution of the serine β-lactamases: past, present and future
Hall, B. G., & Barlow, M. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.02.003 · Cited by 314
Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
McGowan, J. E. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.226 · Cited by 312
Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections
Moran, G. J., Amii, R. N., Abrahamian, F. M., & Talan, D. A. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.040641 · Cited by 278
The Antibiotic Pipeline — Challenges, Costs, and Values
Wenzel, R. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048093 · Cited by 230
Tuberculosis Drug Resistance: A Global Threat
Nachega, J. B., & Chaisson, R. E. (2003) · Clinical Infectious Diseases · doi:10.1086/344657 · Cited by 225
Multi-drug resistant typhoid: a global problem
Mirza, S. H., Beechmg, N. J., & Hart, C. A. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-44-5-317 · Cited by 202
Archean microfossils: a reappraisal of early life on Earth
Altermann, W., & Kazmierczak, J. (2003) · Research in Microbiology · doi:10.1016/j.resmic.2003.08.006 · Cited by 171
Trends in Antimicrobial Resistance in Health Care–Associated Pathogens and Effect on Treatment
McDonald, L. C. (2005) · Clinical Infectious Diseases · doi:10.1086/499404 · Cited by 148
Streptococcus pneumoniae and community-acquired pneumonia: A cause for concern
File, T. M. (2004) · The American Journal of Medicine Supplements · doi:10.1016/j.amjmed.2004.07.007 · Cited by 138
Emerging and Reemerging Infectious Diseases: The Perpetual Challenge
Fauci, A. S. (2005) · Academic Medicine · doi:10.1097/00001888-200512000-00002 · Cited by 123
Outbreak of Multidrug-ResistantSalmonellaNewport—United States, January-April 2002
Zansky, S. M., Wallace, B. J., Schoonmaker-Bopp, D. J., Smith, P. B., Ramsey, F., Painter, J. E., Gupta, A., Kalluri, P., & Noviello, S. (2002) · JAMA · doi:10.1001/jama.288.8.951-jwr0828-2-1 · Cited by 117
Vankayalapati, R., Wizel, B., Weis, S. E., Klucar, P., Shams, H., Samten, B., & Barnes, P. F. (2003) · Clinical Infectious Diseases · doi:10.1086/344903 · Cited by 103
Anti-infective research and development—problems, challenges, and solutions
Bradley, J. S., Guidos, R., Baragona, S., Bartlett, J. G., Rubinstein, E., Zhanel, G. G., Tino, M. D., Pompliano, D. L., Tally, F., Tipirneni, P., et al. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70689-2 · Cited by 99
Self-citationKays, M. B., Smith, D. W., Wack, M. F., & Denys, G. A. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.5.395.33185 · Cited by 93
Extending the cure policy responses to the growing threat of antibiotic resistance
Laxminarayan, R., & Malani, A. (2007) · Cited by 90
Multidrug-Resistant Tuberculosis
Nettleman, M. D. (2005) · JAMA · doi:10.1001/jama.293.22.2788 · Cited by 90
Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit — an infection control study
Douglas, M. W., Mulholland, K., Denyer, V., & Gottlieb, T. (2001) · Burns · doi:10.1016/s0305-4179(00)00084-x · Cited by 83
Multidrug Resistance Among Persons With Tuberculosis in California, 1994-2003
Granich, R. (2005) · JAMA · doi:10.1001/jama.293.22.2732 · Cited by 75
Gordon, K. A., Biedenbach, D. J., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00087-7 · Cited by 71
Management of Overactive Bladder and Urge Urinary Incontinence in the Elderly Patient
Erdem, N., & Chu, F. M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.12.014 · Cited by 70
Outbreak of Multidrug-Resistant Salmonella Newport--United States, January-April 2002
(2002) · JAMA · doi:10.1001/jama.288.8.951 · Cited by 58
Shull, C. A. (1935) · Botanical Gazette · doi:10.1086/334577 · Cited by 56
Development of drugs for antimicrobial-resistant pathogens
Powers, J. H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00006 · Cited by 41
Role of surgery in multi-drug-resistant tuberculosis: results of 27 cases
Kır, A., Tahaoğlu, K., Okur, E., & Hatipoğlu, T. (1997) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(97)00230-3 · Cited by 37
Spellberg, B. J., Miller, L. G., Kuo, M. N., Bradley, J. S., Scheld, W. M., & Edwards, J. E. (2007) · Infection · doi:10.1007/s15010-007-6269-7 · Cited by 32
Self-citationMuller, M. P., McGeer, A., Willey, B. M., Reynolds, D., Malanczyj, R., Silverman, M. R., Green, M. A., & Culf, M. (2002) · PubMed · Cited by 23
Rhomberg, P. R., Fritsche, T. R., Sader, H. S., et al. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.10.010 · Cited by 22
Is There Hope for the Prevention of Future Antimicrobial Shortages?
Gilbert, D. N., & Edwards, J. E. (2002) · Clinical Infectious Diseases · doi:10.1086/341958 · Cited by 19
Self-citationBusiness Aspects of Infectious Diseases
Tenenbaum, M. J., & Petrak, R. M. (2002) · Clinical Infectious Diseases · doi:10.1086/324577 · Cited by 8
T.G. Heaton, Tuberculosis, and Artificial Pneumothorax
Grant, G. R., Lederman, J. A., & Rrandstetter, R. D. (1997) · CHEST Journal · doi:10.1378/chest.112.1.7 · Cited by 7
Cited by
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Self-citationThe global threat of antimicrobial resistance: science for intervention.
Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106
Non-prescription antimicrobial use worldwide: a systematic review
Morgan, D. J., Okeke, I. N., Laxminarayan, R., Perencevich, E. N., & Weisenberg, S. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70054-8 · Cited by 947
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
The multifaceted roles of antibiotics and antibiotic resistance in nature
Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00047 · Cited by 629
Metadata
- Authors
- Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-15
- Volume
- 46
- Issue
- 2
- Pages
- 155-164
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2119629693
- Cited by
- 1,642
- References
- 60
- FWCI
- 54.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.